NCT02605915 · Interventional trial
Safety and Pharmacokinetics of Atezolizumab Combination Treatments in Participants With HER2-Positive and HER2-Negative Breast Cancer
Overall registry status Completed
Phase 1
Conditions HER2-Negative Metastatic Breast Cancer, HER2-Positive Metastatic Breast Cancer, Locally Advanced or Early Breast Cancer
Delaware Valley sites
- Kimmel Cancer Center Thomas Jefferson University · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory